Dirk Pamperin
Direttore/Membro del Consiglio presso SYNTHAVERSE S.A.
Posizioni attive di Dirk Pamperin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SYNTHAVERSE S.A. | Direttore/Membro del Consiglio | 01/01/2020 | - |
APOGEPHA Arzneimittel GmbH
 APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Amministratore Delegato | 01/01/2018 | - |
| Direttore Tecnico/Scientifico/R&S | 01/01/2012 | 01/01/2018 |
Storia della carriera di Dirk Pamperin
Precedenti posizioni note di Dirk Pamperin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Synthon BV
 Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Direttore Tecnico/Scientifico/R&S | 01/01/2005 | 01/01/2012 |
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Corporate Officer/Principal | 01/01/1998 | 01/01/2005 |
Formazione di Dirk Pamperin
| Technische Universität Braunschweig | Undergraduate Degree |
| Universität Stuttgart | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 4 |
| Polonia | 2 |
| Paesi Bassi | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SYNTHAVERSE S.A. | Health Technology |
| Aziende private | 2 |
|---|---|
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Health Services |
Synthon BV
Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Dirk Pamperin
- Esperienza
